Substituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitors
US6090821A · kind A · utility
3Cited by
8References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 1999 |
| Grant date | Jul 18, 2000 |
| Priority date | — |
| Expiry date | Jun 29, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/54
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates generally to quinolin-2(1H)-ones and derivatives thereof of Formula (I): ##STR1## or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as assay standards or reagents, and intermediates and processes for making the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.